Recently wrote for #NatureMedicine this postmortem of the Oxford/AZ mucosal Covid vaccine trial. The intranasal spray version of ChAdOx1 failed to induce strong antibody responses.
But the column also includes a bit on the positive outcome of CanSino's trial using an inhaler (approved as a booster for 2x Coronavac).